Get the Stockscreener App
6.53
1.36%
-0.09
After Hours:
6.38
-0.15
-2.30%
Cullinan Therapeutics Inc stock is traded at $6.53, with a volume of 753.13K.
It is down -1.36% in the last 24 hours and down -10.18% over the past month.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
See More
Previous Close:
$6.62
Open:
$6.57
24h Volume:
753.13K
Relative Volume:
1.89
Market Cap:
$385.76M
Revenue:
-
Net Income/Loss:
$-153.16M
P/E Ratio:
-1.7696
EPS:
-3.69
Net Cash Flow:
$-134.48M
1W Performance:
-6.58%
1M Performance:
-10.18%
6M Performance:
-28.08%
1Y Performance:
-62.94%
1-Day Range:
$6.37
$6.76
1-Week Range:
$6.37
$7.09
52-Week Range:
$6.37
$18.62
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
Name
Cullinan Therapeutics Inc
Sector
Industry
Phone
617-410-4650
Address
ONE MAIN STREET, CAMBRIDGE
Compare CGEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEM
Cullinan Therapeutics Inc
|
6.53 | 382.21M | 0 | -153.16M | -134.48M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Resumed | H.C. Wainwright | Buy |
| Jun-11-25 | Resumed | Stifel | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| May-01-24 | Initiated | Stifel | Buy |
| Apr-15-24 | Initiated | William Blair | Outperform |
| Feb-15-24 | Initiated | Wedbush | Outperform |
| Jun-15-23 | Initiated | TD Cowen | Outperform |
| Nov-21-22 | Initiated | BTIG Research | Buy |
| Apr-27-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Feb-02-21 | Initiated | Evercore ISI | Outperform |
| Feb-02-21 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-02-21 | Initiated | SVB Leerink | Outperform |
| Feb-01-21 | Initiated | H.C. Wainwright | Buy |
View All
Cullinan Therapeutics Inc Stock (CGEM) Latest News
Will Cullinan Therapeutics Inc. see short term momentumEarnings Summary Report & AI Driven Price Predictions - Newser
Will earnings trigger a reversal in Cullinan Therapeutics Inc.2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser
Applying Elliott Wave Theory to Cullinan Therapeutics Inc.Market Rally & Risk Managed Investment Strategies - Newser
Ranking Cullinan Therapeutics Inc. among high performing stocks via toolsQuarterly Portfolio Summary & Expert Curated Trade Setup Alerts - Newser
Top chart patterns to watch in Cullinan Therapeutics Inc.July 2025 Spike Watch & Weekly Chart Analysis and Trade Guides - Newser
What institutional flow reveals about Cullinan Therapeutics Inc.Quarterly Market Review & Long-Term Growth Portfolio Plans - Newser
Trexquant Investment LP Takes Position in Cullinan Therapeutics, Inc. $CGEM - MarketBeat
Will Cullinan Therapeutics Inc. continue its uptrend2025 Technical Patterns & Risk Managed Investment Signals - Newser
What’s the recovery path for long term holders of Cullinan Therapeutics Inc.July 2025 Fed Impact & Advanced Technical Signal Analysis - Newser
Combining price and volume data for Cullinan Therapeutics Inc.Earnings Growth Report & High Accuracy Swing Trade Signals - Newser
Cullinan Therapeutics Inc. stock trend outlook and recovery pathMarket Movers & Fast Entry High Yield Tips - Newser
What candlestick patterns are forming on Cullinan Therapeutics Inc.Market Rally & Long-Term Growth Stock Strategies - Newser
What to do if you’re stuck in Cullinan Therapeutics Inc.Trade Volume Summary & Consistent Profit Alerts - Newser
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum - GlobeNewswire
Leading Biotech Cullinan Therapeutics to Share Targeted Therapy Pipeline at Stifel 2025 Immunology Forum - Stock Titan
Real time scanner hits for Cullinan Therapeutics Inc. explainedJuly 2025 Final Week & Expert Approved Trade Ideas - Newser
What MACD signals say about Cullinan Therapeutics Inc.Chart Signals & Community Trade Idea Sharing Platform - Newser
Analyzing drawdowns of Cullinan Therapeutics Inc. with statistical tools2025 Key Lessons & Long-Term Capital Growth Strategies - Newser
Published on: 2025-09-12 03:40:51 - Newser
Multi factor analysis applied to Cullinan Therapeutics Inc.July 2025 Trends & Risk Managed Investment Signals - Newser
Automated trading signals detected on Cullinan Therapeutics Inc.2025 Historical Comparison & Growth Oriented Trade Recommendations - Newser
Building trade automation scripts for Cullinan Therapeutics Inc.Trade Performance Summary & Consistent Income Trade Ideas - Newser
Chart overlay techniques for tracking Cullinan Therapeutics Inc.2025 Key Lessons & Detailed Earnings Play Alerts - Newser
Can trapped investors hope for a rebound in Cullinan Therapeutics Inc.2025 Top Decliners & Low Risk Growth Stock Ideas - Newser
Cullinan Therapeutics to Participate in Upcoming Investor Conferences - 富途牛牛
When is the best time to exit Cullinan Therapeutics Inc.July 2025 Outlook & Free Technical Pattern Based Buy Signals - Newser
Cullinan Therapeutics, Inc. $CGEM Shares Sold by Walleye Capital LLC - MarketBeat
Risk vs reward if holding onto Cullinan Therapeutics Inc.July 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Transcript : Cullinan Therapeutics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-10-2025 08 - MarketScreener
Statistical indicators supporting Cullinan Therapeutics Inc.’s strengthGlobal Markets & Consistent Profit Trading Strategies - Newser
Chart based analysis of Cullinan Therapeutics Inc. trendsPortfolio Return Report & Long-Term Growth Plans - Newser
What makes Watts Water Technologies, Inc. stock price move sharply - Newser
Measuring Cullinan Therapeutics Inc.’s beta against major indicesOptions Play & Precise Trade Entry Recommendations - Newser
Using RSI to spot recovery in Cullinan Therapeutics Inc.Weekly Loss Report & Verified Momentum Watchlists - Newser
Published on: 2025-09-09 23:45:11 - Newser
Will a bounce in Cullinan Therapeutics Inc. offer an exitJuly 2025 Action & Expert Curated Trade Setups - Newser
Analyzing net buyer seller activity in Cullinan Therapeutics Inc.Weekly Volume Report & Free AI Powered Buy and Sell Recommendations - Newser
Cullinan Therapeutics Inc Stock (CGEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):